ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
37K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
3 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
37K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
37K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
37K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
37K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
4 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
37K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
9 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
37K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
37K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
jimnycricket
|
159 |
37K |
12 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
37K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
jimnycricket
|
206 |
52K |
5 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
206
|
52K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
jimnycricket
|
206 |
52K |
8 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
206
|
52K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
jimnycricket
|
206 |
52K |
18 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
206
|
52K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
jimnycricket
|
206 |
52K |
9 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
206
|
52K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
jimnycricket
|
563 |
136K |
11 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
563
|
136K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
jimnycricket
|
563 |
136K |
11 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
563
|
136K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
jimnycricket
|
563 |
136K |
10 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
563
|
136K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
jimnycricket
|
206 |
52K |
11 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
206
|
52K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
jimnycricket
|
206 |
52K |
17 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
206
|
52K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
jimnycricket
|
563 |
136K |
41 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
563
|
136K
|
41
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
jimnycricket
|
563 |
136K |
12 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
563
|
136K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
jimnycricket
|
563 |
136K |
8 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
563
|
136K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
jimnycricket
|
250 |
63K |
21 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
63K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
jimnycricket
|
250 |
63K |
3 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
250
|
63K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
jimnycricket
|
250 |
63K |
3 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
250
|
63K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
jimnycricket
|
250 |
63K |
7 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
250
|
63K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
jimnycricket
|
250 |
63K |
17 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
63K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
jimnycricket
|
1.4K |
363K |
23 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.4K
|
363K
|
23
|
|